Are Trigger Finger Injections Painful?

Trigger finger injections cause moderate, brief pain for most people, typically rated around 4 to 6 out of 10 on a standard pain scale, and the needle portion is over in seconds. That puts the sensation roughly on par with a blood draw from a sensitive spot or a dental injection, though individual experiences vary quite a bit depending on the injection site, whether a local anesthetic is mixed in, and even the patient’s mental state going in. The good news is that the discomfort is fleeting, and several factors within your doctor’s control can shift it meaningfully in either direction.

What the Numbers Say About Injection Pain

Researchers measure injection pain using a visual analog scale (VAS), where 0 means no pain and 10 is the worst imaginable. Across multiple trials, trigger finger injection pain during the procedure clusters in the range of roughly 4 to 7 out of 10 when no special pain-reduction techniques are used. One study found average pain scores of about 6.0 to 6.8 depending on which palm-side approach was used.¹ Another found that patients who received steroid without any local anesthetic reported average pain of about 6.2 during the injection itself.² A separate study that tracked both anticipated and actual pain found that people generally expected scores in the mid-4 to 5 range but actually experienced scores closer to 5.5 to 6.3, slightly worse than they anticipated.³

The important context here is that the sharp part of the experience lasts only a few seconds. A study looking at pain predictors found that average injection pain was about 4.3 out of 10, and pain the following day had already dropped to about 1.8.⁴ So while the moment of injection is uncomfortable, the pain resolves quickly for the majority of patients. Most people can drive home and use their hand normally within minutes.

Where the Needle Goes Changes the Experience

Your doctor chooses an injection site based on anatomy and personal preference, but that choice makes a real difference in how much the needle hurts. There are two broad approaches: going in through the palm side of the hand (the traditional route) or entering through the skin between the fingers on the back of the hand, called the dorsal web space.

A randomized trial comparing these two routes found that the dorsal web space approach hurt considerably less, with patients scoring it about 3.6 out of 10 versus 5.4 for the standard palmar injection. Both approaches were equally effective at resolving the trigger finger itself.⁵ The likely reason is that the skin on the back of the hand has fewer densely packed nerve endings than the palm, which is one of the most sensitive areas of the body.

Within palm-side approaches, there are variations too: some doctors inject closer to the base of the finger, others more toward the middle of the palm, and some enter at a slightly different angle. One trial comparing three palmar techniques found that pain scores ranged from about 6.0 to 6.8, with no statistically significant difference among them.¹ In other words, once you’re going through the palm, the specific palmar site matters less than whether you’re going through the palm at all versus the web space between fingers. If pain is a concern for you, it’s worth asking your doctor whether the dorsal web space approach is an option for your particular finger.

Mixing in Local Anesthetic Makes a Noticeable Difference

Some doctors inject the steroid alone; others mix it with a local anesthetic like lidocaine. A 2024 randomized trial tested this directly: patients who received lidocaine combined with the steroid reported pain of about 4.6 during the injection, compared to 6.2 in patients who received steroid alone. An hour later, the lidocaine group was still doing better, with pain scores of about 1.3 versus 2.5. By six hours, though, the difference had vanished, and by two days both groups were essentially pain-free.² The success rates for resolving the trigger finger itself were nearly identical regardless of whether lidocaine was included, so the anesthetic is purely about comfort during and just after the injection.

A point and a half on a 10-point pain scale might sound small, but in practical terms it’s the difference between “that really stung” and “that was unpleasant but manageable.” If you’re anxious about the injection, asking your doctor to include a local anesthetic is a reasonable request, and the evidence suggests it won’t compromise the treatment.

Tricks That Sound Like They Should Work but Don’t

Ethyl chloride is a vapocoolant spray that numbs the skin with cold before the needle goes in. It’s widely used in clinics and intuitively seems like it should help. But a study of over 150 patients getting hand injections found no difference whatsoever in injection pain between the spray group and the no-spray group. Subgroup analysis didn’t rescue it either: the spray failed equally across men and women, anxious and calm patients, and people with high or low pain thresholds.⁶ The likely explanation is that trigger finger injections go deeper than the superficial skin layer the spray numbs, so cooling the surface doesn’t address where most of the pain originates.

Buffering the injection solution with sodium bicarbonate is another approach that has theoretical appeal. Steroid mixtures are acidic, and acidic solutions sting more going in. Making the solution pH-neutral should, in theory, reduce the burn. A double-blind randomized trial tested this for trigger finger and de Quervain’s injections, and the buffered solution offered no meaningful reduction in flare reactions compared to the standard acidic version.⁷ Buffering has shown benefits for some other types of injections, but for trigger finger specifically, the evidence doesn’t support it.

Vibration Devices Are an Exception

One pain-reduction strategy that does appear to work is applying a vibrating device near the injection site during the procedure. The idea is based on gate control theory: the vibration stimulates touch and pressure nerve fibers in a way that partially blocks pain signals. A 2024 randomized trial of upper extremity injections found that patients in the vibration group reported pain of about 4 out of 10 immediately after the injection, compared to about 7.4 in the control group. That’s a drop of nearly half, and the vibration group also reported significantly higher satisfaction and comfort.⁸ Not every clinic has these devices, but they’re commercially available and inexpensive, so it’s worth asking about.

The Steroid Flare After the Injection

Even if the injection itself goes smoothly, a significant number of patients experience what’s called a steroid flare in the hours or days afterward. This is a temporary worsening of pain and sometimes swelling at the injection site, typically starting six to 36 hours after the procedure and lasting one to three days. It’s caused by the crystalline structure of the steroid precipitating out of solution in the tissue, triggering a local inflammatory reaction. It’s not an infection or an allergic reaction, and it resolves on its own, but it can be genuinely unpleasant and catches people off guard if they’re not warned.

A trial comparing two common steroids, betamethasone and methylprednisolone, found that flare reactions with betamethasone occurred at roughly double the rate of those with methylprednisolone, though the difference wasn’t quite statistically significant given the study size.⁹ Ice, over-the-counter anti-inflammatory medication, and patience are the standard management. If your doctor gives you the choice of steroid type and you’re particularly worried about post-injection soreness, this is a conversation worth having.

Why Some People Hurt More Than Others

There’s a wide spread in pain scores across patients even when the injection technique is identical, and research points to psychological factors as a surprisingly large piece of the puzzle. A study examining predictors of injection pain found that expected pain (how much you thought it would hurt going in), depression, catastrophic thinking, and being female were all correlated with higher pain during the injection. Together with the identity of the treating physician, these factors explained about 28% of the variability in pain scores.⁴

That 28% figure is telling. It means your psychological state walking into the office has a measurable effect on how much the needle actually hurts, not just on how you remember it afterward. Catastrophic thinking here doesn’t mean anything extreme; it refers to the tendency to ruminate on worst-case scenarios, magnify the threat, and feel helpless about it. Even mild anxiety can amplify pain perception. This isn’t a “just relax” dismissal. Rather, it suggests that simple strategies like deep breathing, distraction, or even being warned honestly about what to expect can make the experience more tolerable. The study also found that anticipated pain, in particular, tracked closely with actual pain. Being told by a friend that the injection was terrible can, in a measurable way, make yours worse.

The physician factor is also interesting. Different doctors had different average pain scores for their patients, even controlling for technique. This probably reflects a mix of bedside manner, injection speed, needle gauge preferences, and how well they position the patient. If you have a choice of provider, prior patient experience isn’t a bad thing to ask about.

How Well Do the Injections Work

Understanding the pain in context requires knowing what you get for it. On a short-term basis, the results are solid: one study found that a single steroid injection effectively resolved symptoms in about two-thirds of trigger finger cases.¹⁰ For recurrent cases that come back after a first injection, a repeat shot can still work well initially. A prospective study of repeated injections for recurrent trigger fingers found success rates of about 97% at one month, 84% at three months, and 68% at six months, though by one year only about half of patients remained symptom-free.¹¹

Long-term data is more sobering. A study tracking patients after a single corticosteroid injection found that only about 45% maintained treatment success over the long term. Women presenting with their first trigger finger did best, with about a 56% ten-year success rate, while men presenting for the first time and patients with multiple affected fingers all hovered around 35 to 39%. Most failures showed up within the first two years.¹² So while the injection offers meaningful relief for months and often longer, it isn’t a permanent fix for everyone. For many people, it buys enough time that the problem doesn’t come back. For others, it’s a bridge to a decision about surgery.

Diabetes Makes Things Harder

If you have diabetes, trigger finger injections work less reliably. As a group, diabetic patients see about a 50% symptom resolution rate from steroid injections, compared to considerably higher rates in the general population. Insulin-dependent patients fare worse still, with a higher likelihood of multiple fingers being involved and a greater chance of ultimately needing surgery.¹³

A prospective randomized trial confirmed this disparity more rigorously. After one or two injections, about 86% of non-diabetic digits had a successful outcome, compared to roughly 63% in the diabetic corticosteroid group. Diabetic patients with complications like nephropathy or neuropathy were significantly more likely to need surgery.¹⁴ Diabetes also complicates the picture because steroid injections can cause temporary blood sugar spikes, sometimes lasting several days. If you have diabetes, your doctor should be aware so they can advise on monitoring and dose adjustments.

Ultrasound Guidance Doesn’t Clearly Reduce Pain

You might assume that using ultrasound to guide the needle precisely to the right spot would hurt less and work better. The intuition makes sense: if the needle goes exactly where it needs to, there should be less poking around. But for trigger finger specifically, a study comparing ultrasound-guided and blind (landmark-based) injections found no significant differences in pain levels or clinical outcomes at six weeks or six months.¹⁵ The A1 pulley where the injection needs to go is located at a consistent, predictable spot at the base of the finger, so experienced clinicians can hit the target reliably without imaging. Ultrasound guidance becomes more valuable for deeper or less predictable joints, but for trigger fingers it appears to add cost without clear benefit.

Splinting as a Pain-Free Alternative

For people who find the idea of a needle in the palm genuinely distressing, it’s worth knowing that splinting is a legitimate first-line treatment. A randomized trial comparing steroid injection alone, splinting alone, and a combination of both found no clinically important differences in pain scores or hand function across the three groups at any time point measured.¹⁶ Splinting typically involves wearing a rigid or semi-rigid brace on the affected finger for six to nine weeks, limiting the motion that aggravates the inflamed tendon sheath. The tradeoff is time and inconvenience: splinting takes weeks to show results, while an injection often resolves pain within days and catching or locking within a few weeks.

When conservative approaches fail, surgery is highly effective. A trial comparing corticosteroid injection, percutaneous release, and open surgery found that injection achieved a trigger cure rate of about 57% after one injection and 86% after a second, while both surgical methods achieved remission in all cases.¹⁷ Surgery obviously involves its own recovery and discomfort, but for recurrent or severe trigger fingers that don’t respond to one or two injections, it’s the definitive solution.

Children and Trigger Finger Injections

Trigger finger in children is a fundamentally different condition from the adult version, even though the name is the same. In adults, trigger finger is typically caused by repetitive use, age-related changes, or systemic conditions like diabetes that thicken the tendon sheath. In children, the causes are more complex and less predictable, and the treatment approach differs accordingly. Conservative treatment outcomes in pediatric patients are less consistent, and the role of corticosteroid injections is less established than in adults. Many pediatric hand specialists lean toward observation first, since some childhood cases resolve spontaneously, and move to surgical release rather than injections when intervention is needed. If your child has a triggering finger, the decision tree looks quite different from the adult version, and a pediatric hand specialist is the right person to navigate it.

1
PubMed Central. The Effect of Trigger Finger Injection Site on Injection-Related Pain
2
PubMed. Corticosteroid Injection With and Without Local Anesthetic for the Treatment of Trigger Finger: A Randomized Clinical Trial
3
The Journal of Hand Surgery. The Efficacy of 95-Hz Topical Vibration in Pain Reduction for Trigger Finger Injection: A Placebo-Controlled, Prospective, Randomized Trial
4
The Journal of Hand Surgery. Predictors of pain during and the day after corticosteroid injection for idiopathic trigger finger
5
PubMed. A randomized controlled trial of dorsal web space versus palmar midline injection of steroid in the treatment of trigger digits
6
PubMed. Use and Effectiveness of Ethyl Chloride for Hand Injections
7
PubMed. Extra-articular steroid injection: early patient response and the incidence of flare reaction
8
PubMed Central. Effectiveness of using a vibration device to ease pain during upper extremity injections: A randomized controlled trial
9
PubMed Central. Comparing the Intensity of Pain and Incidence of Flare Reaction Following Trigger Finger Injections Using Betamethasone and Methylprednisolone: A Double-Blinded, Randomized Controlled Trial
10
PubMed Central. The efficacy of steroid injection in the treatment of trigger finger
11
PubMed. Factors Influencing the Successful Treatment of Recurrent Trigger Finger With Repeated Corticosteroid Injections: A Prospective Cohort Study
12
PubMed Central. Long-Term Outcomes Following a Single Corticosteroid Injection for Trigger Finger
13
PubMed. Treatment of trigger finger in patients with diabetes mellitus
14
Journal of Bone and Joint Surgery. Corticosteroid Injection in Diabetic Patients with Trigger Finger: A Prospective, Randomized, Controlled Double-Blinded Study
15
PubMed. Corticosteroid injection for trigger finger: blinded or ultrasound-guided injection?
16
PubMed Central. Are There Differences in Pain Reduction and Functional Improvement Among Splint Alone, Steroid Alone, and Combination for the Treatment of Adults With Trigger Finger?
17
Oxford Academic (Rheumatology). Treatment of trigger finger: randomized clinical trial comparing the methods of corticosteroid injection, percutaneous release and open surgery